Medtronic earns FDA approval for insertable cardiac monitor

Mackenzie Bean -

Medtronic received market clearance from the Food and Drug Administration for its insertable cardiac monitor.

Clinicians insert the Reveal LINQ Insertable Cardiac Monitor in the upper left side of a patient's chest during a minimally invasive procedure. The implanted device allows clinicians to continuously monitor a patient's heartbeat for up to three years, according to a company news release.

The device uses wireless communication to upload device data, and patients can undergo MRIs while using the implanted device.

More articles on supply chain:

Patients often skip, delay or ration cancer treatments due to high drug costs: 5 takeaways
7 things to know about Dr. Scott Gottlieb's relationship with the drug industry
Mylan settles biosimilar patent dispute with Roche: 4 things to know


Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.